Global Infectious Disease Diagnostics Market : Industry Analysis & Forecast (2019-2024) _ by Product (Instruments, Consumables, Software and Services), by Technology, by End-User (Hospital Laboratories, Reference Labs, Physician’s Office Labs, and others), by Application, and by Geography

Global Infectious Disease Diagnostics Market : Industry Analysis & Forecast (2019-2024) _ by Product (Instruments, Consumables, Software and Services), by Technology, by End-User (Hospital Laboratories, Reference Labs, Physician’s Office Labs, and others), by Application, and by Geography

Market Scenario

Global Infectious Disease Diagnostics Market is expected to increase from USD 17.26 Billion in 2018 to USD XXBillion in 2026 at a CAGR XX %. infectious disease, also known as infectiology, is a medical specialty dealing with the diagnosis, control and treatment of infections. An infectious disease specialist's practice may consist largely of managing nosocomial (hospital-acquired) infections, or it may be out-patient based. This growing demand for portable and accurate detection devices,  high prevalence rate of infectious disease, increase in government funding are the main factors for the market enhancement. Infectious diseases are highly common in under-developed countries due to a lack of awareness for proper hygiene, an absence of good physician services, and minimal healthcare expenditures. Global Infectious Disease Diagnostics Market The Asia-Pacific market is expected to grow rapidly in the forecast period owing to increase in the prevalence of infectious diseases, The increment in the expenditure in R&D, increased funding from various government and private organizations, and increasing demand for new diagnostic tests for the control of infectious diseases. The trend and advancement for personalized healthcare are on a continuous rise, bringing the molecular testing to the point of care to the patient’s home, doctor’s clinics and the hospital will be in continuous demand. China and India are projected to be the fastest growing markets in the Asia-Pacific region. Moreover, the increasing numbers of chronic infectious diseases with the presence of government initiatives aimed to promote early diagnosis are the factors expected to fuel regional progress. The Global Infectious Disease Diagnostics Market is segmented on the basis of product, technology, application, end-user, and region. On the basis of products, the market is segmented into instruments and analyzers, consumables (assays and reagents), and software & services. On the basis of technology, the market is segmented into traditional methods and molecular diagnostics. Based on application, the market is divided into Hepatitis B, Hepatitis C, acquired immunodeficiency syndrome (AIDS), tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoea (CT/NG), Human papillomavirus (HPV) infection and hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection, and others (influenza, Ebola, typhoid, malaria, and dengue among others). Based on end-users, the market is segmented into hospital laboratories, reference labs, physician’s office labs, academics and others (blood banks, local public health laboratories, home health agencies, nursing homes, the point of care, self-testing). On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and other regions. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Infectious Disease Diagnostics Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment shortly to the emerging segment in the Global Infectious Disease Diagnostics Market. Key Highlights: •  Global Infectious Disease Diagnostics Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Infectious Disease Diagnostics Market. •  Global Infectious Disease Diagnostics Market segmentation on the basis of product, technology, end-user, application, and region (country-wise) has been provided. • Global Infectious Disease Diagnostics Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of the study. • Global Infectious Disease Diagnostics Market analysis and forecast for the global market. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Infectious Disease Diagnostics Market are also profiled. Research Methodology: Bloomberg, Factiva, and Hoovers are some of the sites that are being referred to gain insights about Global Infectious Disease Diagnostics Market. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the Global size of Global Infectious Disease Diagnostics Market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global Infectious Disease Diagnostics Market. Some of the major companies operating in Infectious Disease Diagnostics: • F. Hoffmann-La Roche Ltd • Abbott Diagnostics • bioMérieux SA • Becton-Dickinson & Company • Siemens Healthineers • Thermo Fischer Scientific, Inc. • Bio-Rad Laboratories • Sysmex Corporation • Beckman Coulter • Danaher Corporation • Alere Inc. • Chembio Diagnostics Inc. • Cepheid Inc • DiaSorin • Meridian Bioscience • Trinity Biotech • Sekisui Diagnostics • Quidel Corporation • MedMira, Inc. • Calypte Biomedical Corporation Years considered to estimate the market size of the Global Infectious Disease Diagnostics Market have been mentioned below: • Base year: 20188 • Estimated year: 2019 • Forecast year: 2019 to 2026 The scope of the Report: This research report segments the Global Infectious Disease Diagnostics Market based on product type, technology, application, end-user, and geography. Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Infectious Disease Diagnostics Market with key developments in companies and market trends. Global Infectious Disease Diagnostics Market, by Product: • Instruments • Consumables • Software and Services Global Infectious Disease Diagnostics Market, by Technology: • Traditional Methods  Immunodiagnostics  Microscopy  Biochemical characterization • Molecular Diagnostics  Polymerase Chain Reaction (PCR)  INAAT (Isothermal Nucleic Acid Amplification Test)  Hybridization  DNA Sequencing & Next Generation Sequencing  Mass Spectroscopy  Others (electrophoresis, mass spectrometry, and flow cytometry) Global Infectious Disease Diagnostics Market, by End-User: • Hospital laboratories • Reference Labs • Physician’s Office Labs • Academics • Clinics • Home • Assisted Living Healthcare Facilities • Others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care, self-testing) Global Infectious Disease Diagnostics Market, by Application: • Hepatitis B • Hepatitis C • Acquired Immunodeficiency Syndrome (AIDS) • Tuberculosis (TB) • Chlamydia Trachomatis and Gonorrhoea • Human Papillomavirus (HPV) • Methicillin-resistant Staphylococcus aureus (MRSA) • Others. Global Infectious Disease Diagnostics Market, by Geography: • North America • Europe • Asia Pacific • Middle East & Africa • Latin America • Others Geographic Analysis: • Breakdown of The North America Global Infectious Disease Diagnostics Market • Breakdown of The Europe Global Infectious Disease Diagnostics Market • Breakdown of The Asia Pacific Global Infectious Disease Diagnostics Market • Breakdown of The Middle East & Africa Global Infectious Disease Diagnostics Market • Breakdown of The Latin America Global Infectious Disease Diagnostics Market Available Customization : Maximize Market Research offers customization of reports according to the specific requirement of our clients. Global 3D Bioprinting Market – Industry Analysis and Forecast 

Table of Contents

1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET DYNAMICS 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunists 4. END-USER OVERVIEW 4.1. Value Chain Analysis 4.2. Global Infectious Disease Diagnostics Market Industry Trends and Emerging Technologies 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT (2019-2026) 5.1. Introduction 5.2. Instruments 5.2.1. Instrument Market overview 5.2.2. Instrument Market Size and Forecast 5.3. Global Infectious Disease Diagnostics Market, By Consumables 5.3.1. Consumables Market overview 5.3.2. Consumables Market Size and Forecast 5.4. Global Infectious Disease Diagnostics Market, By Software and Service 5.4.1. Software and Service Market overview 5.4.2. Software and Service Market Size and Forecast 6. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY (2019-2026) 6.1. Introduction 6.2. Traditional Methods 6.2.1. Traditional Methods Market overview 6.2.2. Traditional Methods Market Size and Forecast 6.3. Immunodiagnostics Market 6.3.1.1. Immunodiagnostics Market Overview 6.3.1.2. Immunodiagnostics Market Size and Forecast 6.4. Microscopy Market 6.4.1.1. Microscopy Market Overview 6.4.1.2. Microscopy Market Size and Forecast 6.5. Biochemical Characterization Market 6.5.1.1. Biochemical Characterization Market Overview 6.5.1.2. Biochemical Characterization Market Size and Forecast 6.6. Global Infectious Disease Diagnostics Market, By Molecular Diagnostics 6.6.1. Molecular Diagnostics Market overview 6.6.2. Molecular Diagnostics Market Size and Forecast 6.7. Polymerase Chain Reaction (PCR) 6.7.1.1. PCR Market Overview 6.7.1.2. PCR Market Size and Forecast 6.8. INAAT (Isothermal Nucleic Acid Amplification Test) 6.8.1.1. INAAT Market Overview 6.8.1.2. INAAT Market Size and Forecast 6.9. Hybridization 6.9.1.1. Hybridization Market Overview 6.9.1.2. Hybridization Market Size and Forecast 6.10. DNA Sequencing & Next Generation Sequencing 6.10.1.1. DNA Sequencing & Next Generation Sequencing Market Overview 6.10.1.2. DNA Sequencing & Next Generation Sequencing Market Size and Forecast 6.11. Mass Spectroscopy 6.11.1.1. Mass Spectroscopy Market Overview 6.11.1.2. Mass Spectroscopy Market Size and Forecast 6.12. Others (electrophoresis, mass spectrometry, and flow cytometry) 6.12.1.1. Others Market Overview 6.12.1.2. Market Size and Forecast 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END-USER (2019-2026) 7.1. Introduction 7.2. Hospital Laboratories 7.2.1. Hospital Laboratories Market overview 7.2.2. Hospital Laboratories Market Size and Forecast 7.3. Reference Labs 7.3.1. Reference Labs Market overview 7.3.2. Reference Labs Market Size and Forecast 7.4. Physician’s Office Labs 7.4.1. Physician’s Office Labs Market overview 7.4.2. Physician’s Office Labs Market Size and Forecast 7.5. Academics 7.5.1. Academics Market overview 7.5.2. Academics Market Size and Forecast 7.6. Clinics 7.6.1. Clinics Market overview 7.6.2. Clinics Market Size and Forecast 7.7. Home 7.7.1. Home Market overview 7.7.2. Home Market Size and Forecast 7.8. Assisted Living Healthcare Facilities 7.8.1. Assisted Living Healthcare Facilities Market overview 7.8.2. Assisted Living Healthcare Facilities Market Size and Forecast 7.9. Others 7.9.1. Others Market overview 7.9.2. Others Market Size and Forecast 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY APPLICATION (2019-2026) 8.1. Introduction 8.2. Hepatitis B 8.2.1. Hepatitis B Market overview 8.2.2. Hepatitis B Market Size and Forecast 8.3. Hepatitis C 8.3.1. Hepatitis C Market overview 8.3.2. Hepatitis C Market Size and Forecast 8.4. By Acquired Immunodeficiency Syndrome (AIDS) 8.4.1. Acquired Immunodeficiency Syndrome (AIDS) Market overview 8.4.2. Acquired Immunodeficiency Syndrome (AIDS) Market Size and Forecast 8.5. Tuberculosis (TB) 8.5.1. Tuberculosis (TB) Market overview 8.5.2. Tuberculosis (TB) Market Size and Forecast 8.6. Chlamydia Trachomatis and Gonorrhoea 8.6.1. Chlamydia Trachomatis and Gonorrhoea Market overview 8.6.2. Chlamydia Trachomatis and Gonorrhoea Market Size and Forecast 8.7. Human Papillomavirus (HPV) 8.7.1. Human Papillomavirus (HPV) Market overview 8.7.2. Human Papillomavirus (HPV) Market Size and Forecast 8.8. Methicillin-resistant Staphylococcus aureus (MRSA) 8.8.1. Methicillin-resistant Staphylococcus aureus (MRSA) Market overview 8.8.2. Methicillin-resistant Staphylococcus aureus (MRSA) Market Size and Forecast 8.9. Others 8.9.1. Others Market overview 8.9.2. Others Market Size and Forecast 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY GEOGRAPHY (2019-2026) 9.1. North America Global Infectious Disease Diagnostics Market 9.1.1. North America Global Infectious Disease Diagnostics Market, by Type 9.1.2. North America Global Infectious Disease Diagnostics Market, by Technology 9.1.3. North America Global Infectious Disease Diagnostics Market, by End-Users 9.1.4. North America Global Infectious Disease Diagnostics Market, by Application 9.1.5. North America Global Global Infectious Disease Diagnostics Market, by Region 9.1.5.1. U.S. Global Infectious Disease Diagnostics Market 9.1.5.2. Canada Global Infectious Disease Diagnostics Market 9.1.5.3. Rest of North America Global Infectious Disease Diagnostics Market 9.2. Europe Global Infectious Disease Diagnostics Market 9.2.1. Europe Global Infectious Disease Diagnostics Market, by Type 9.2.2. Europe Global Infectious Disease Diagnostics Market, by Technology 9.2.3. Europe Global Infectious Disease Diagnostics Market, by End-Users 9.2.4. Europe Global Infectious Disease Diagnostics Market, by Application 9.2.5. Europe Global Infectious Disease Diagnostics Market, by Region 9.2.5.1. France Global Infectious Disease Diagnostics Market 9.2.5.2. Germany Global Infectious Disease Diagnostics Market 9.2.5.3. U.K. Global Infectious Disease Diagnostics Market 9.2.5.4. Spain Global Infectious Disease Diagnostics Market 9.2.5.5. Rest of Europe Global Infectious Disease Diagnostics Market 9.3. Asia Pacific Global Infectious Disease Diagnostics Market 9.3.1. Asia Pacific Global Infectious Disease Diagnostics Market, by Type 9.3.2. Asia Pacific Global Infectious Disease Diagnostics Market, by Technology 9.3.3. Asia Pacific Global Infectious Disease Diagnostics Market, by End-Users 9.3.4. Asia Pacific Global Infectious Disease Diagnostics Market, by Application 9.3.5. Asia-Pacific Global Infectious Disease Diagnostics Market, by Region 9.3.5.1. China Global Infectious Disease Diagnostics Market 9.3.5.2. Japan Global Infectious Disease Diagnostics Market 9.3.5.3. India Global Infectious Disease Diagnostics Market 9.3.5.4. Australia Global Infectious Disease Diagnostics Market 9.3.5.5. South Korea Global Infectious Disease Diagnostics Market 9.3.5.6. Rest of Asia Pacific Global Infectious Disease Diagnostics Market 9.4. Middle east & Africa Global Infectious Disease Diagnostics Market 9.4.1. Middle east & Africa Global Infectious Disease Diagnostics Market, by Type 9.4.2. Middle east & Africa Global Infectious Disease Diagnostics Market, by Technology 9.4.3. Middle east & Africa Global Infectious Disease Diagnostics Market, by End-Users 9.4.4. Middle east & Africa Global Infectious Disease Diagnostics Market, by Application 9.4.5. Middle east & Africa Global Infectious Disease Diagnostics Market, by Region 9.4.5.1. South Africa Global Infectious Disease Diagnostics Market 9.4.5.2. Rest of Middle east & Africa Global Infectious Disease Diagnostics Market 9.5. Latin America Global Infectious Disease Diagnostics Market 9.5.1. Latin America Global Infectious Disease Diagnostics Market, by Type 9.5.2. Latin America Global Infectious Disease Diagnostics Market, by Technology 9.5.3. Latin America Global Infectious Disease Diagnostics Market, by End-Users 9.5.4. Latin America Global Infectious Disease Diagnostics Market, by Application 9.5.5. Latin America Global Infectious Disease Diagnostics Market, by Region 9.5.5.1. Argentina Global Infectious Disease Diagnostics Market 9.5.5.2. Brazil Global Infectious Disease Diagnostics Market 9.5.5.3. Mexico Global Infectious Disease Diagnostics Market 9.5.5.4. Rest of Latin America Global Infectious Disease Diagnostics Market 10. MARKET COMPETITION ANALYSIS 10.1 Market Share/Positioning Analysis 10.2 Key Innovators 10.3 Company Profiles 10.3.1 F. Hoffmann-La Roche Ltd 10.3.1.1 Overview 10.3.1.2 Products/End User 10.3.1.3 Strategy 10.3.1.4 Key Developments 10.3.2 Abbott Diagnostics 10.3.2.1 Overview 10.3.2.2 Products/End User 10.3.2.3 Strategy 10.3.2.4 Key Developments 10.3.3 bioMérieux SA 10.3.3.1 Overview 10.3.3.2 Products/End User 10.3.3.3 Strategy 10.3.3.4 Key Developments 10.3.4 Becton-Dickinson & Company 10.3.4.1 Overview 10.3.4.2 Products/End User 10.3.4.3 Strategy 10.3.4.4 Key Developments 10.3.5 Siemens Healthineers 10.3.5.1 Overview 10.3.5.2 Products/End User 10.3.5.3 Strategy 10.3.5.4 Key Developments 10.3.6 Thermo Fischer Scientific, Inc. 10.3.6.1 Overview 10.3.6.2 Products/End User 10.3.6.3 Strategy 10.3.6.4 Key Developments 10.3.7 Bio-Rad Laboratories 10.3.7.1 Overview 10.3.7.2 Products/End User 10.3.7.3 Strategy 10.3.7.4 Key Developments 10.3.8 Sysmex Corporation 10.3.8.1 Overview 10.3.8.2 Products/End User 10.3.8.3 Strategy 10.3.8.4 Key Developments 10.3.9 Beckman Coulter 10.3.9.1 Overview 10.3.9.2 Products/End User 10.3.9.3 Strategy 10.3.9.4 Key Developments 10.3.10 Danaher Corporation 10.3.10.1 Overview 10.3.10.2 Products/End User 10.3.10.3 Strategy 10.3.10.4 Key Developments 10.3.11 Alere Inc. 10.3.11.1 Overview 10.3.11.2 Products/End User 10.3.11.3 Strategy 10.3.11.4 Key Developments 10.3.12 Chembio Diagnostics Inc. 10.3.12.1 Overview 10.3.12.2 Products/End User 10.3.12.3 Strategy 10.3.12.4 Key Developments 10.3.13 Cepheid Inc 10.3.13.1 Overview 10.3.13.2 Products/End User 10.3.13.3 Strategy 10.3.13.4 Key Developments 10.3.14 DiaSorin 10.3.14.1 Overview 10.3.14.2 Products/End User 10.3.14.3 Strategy 10.3.14.4 Key Developments 10.3.15 Meridian Bioscience 10.3.15.1 Overview 10.3.15.2 Products/End User 10.3.15.3 Strategy 10.3.15.4 Key Developments 10.3.16 Trinity Biotech 10.3.16.1 Overview 10.3.16.2 Products/End User 10.3.16.3 Strategy 10.3.16.4 Key Developments 10.3.17 Sekisui Diagnostics 10.3.17.1 Overview 10.3.17.2 Products/End User 10.3.17.3 Strategy 10.3.17.4 Key Developments 10.3.18 Quidel Corporation 10.3.18.1 Overview 10.3.18.2 Products/End User 10.3.18.3 Strategy 10.3.18.4 Key Developments 10.3.19 MedMira, Inc. 10.3.19.1 Overview 10.3.19.2 Products/End User 10.3.19.3 Strategy 10.3.19.4 Key Developments 10.3.20 Calypte Biomedical Corporation 10.3.20.1 Overview 10.3.20.2 Products/End User 10.3.20.3 Strategy 10.3.20.4 Key Developments

About This Report

Report ID3316
Published DateAugust 2019
Contact Us
Call Now